PLx Pharma Inc. (NASDAQ:PLXP) management will conduct a conference call for 13th November 2020 at 8:30 AM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website plxpharma.com
To participate in the conference call, local and international callers can dial (866) 394-2901 or (616) 548-5567 Toll Number, when prompted, enter passcode 2219797
Earnings Expectation
PLx Pharma Inc. is reporting third quarter financial results on Friday 13th November 2020, before market open.
PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing its PLxGuard delivery system to provide various products in the United States. The companys lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce acute gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention. Its product pipeline also includes other oral non-steroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg, a GI-safer ibuprofen product for pain and inflammation, as well as PL1100 Ibuprofen 400 mg.